Eloxx Pharmaceuticals GAAP EPS of -$0.66 (NASDAQ:ELOX)
· seekingalpha.com
Eloxx Pharmaceuticals press release (ELOX): Q2 GAAP EPS of -$0.66. As of June 30, 2026, the Company had cash and cash equivalents of $62.0 million, which includ
To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
If you have an ad-blocker enabled you may be blocked from ...